Access to new medicines still varies sharply across Europe, with waits ranging from months to more than three years, according to the European Federation of Pharmaceutical Industries and Associations.

Il nuovo Wait Indicator di Efpia segnala un aumento delle disuguaglianze nell’accesso ai farmaci innovativi in Europa. Quasi la metà dei medicinali non è disponibile ai pazienti…

Access to new medicines still varies sharply across Europe, with waits ranging from months to more than three years, according to the European Federation of Pharmaceutical…